Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence
Vitamin K antagonists (VKA) and heparins have been utilized for the prevention and treatment of thromboembolism (arterial and venous) for decades. Targeting and inhibiting specific coagulation factors have led to new discoveries in the pharmacotherapy of thromboembolism management. These targeted an...
Saved in:
Main Authors: | Ali Zalpour, Thein Hlaing Oo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2015/920361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01) -
Analysis of early results of edoxaban and warfarin in the treatment of deep vein thrombosis
by: Abdullah Guner, et al.
Published: (2024-03-01) -
Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial
by: Keiichi Fukuda, et al.
Published: (2022-07-01) -
Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy
by: Kenichi Nitta, et al.
Published: (2016-01-01) -
Population pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients
by: Peng Zou, et al.
Published: (2025-01-01)